Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
An evidence-based clinical practice guideline for dental pain (surgical and non-surgical)
The Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act (known as the SUPPORT Act) was signed into law in October 201 8. Section 3002 of the SUPPORT Act requires the Commissioner of Food and Drugs to develop evidence-based opioid analgesic
prescribing guidelines for indication-specific treatment of acute pain where such guidelines do not exist.
Consistent with the requirements of section 3002 of the SUPPORT Act, FDA launched an effort to develop a framework for evidence-based guidelines involving a contract with the National Academies of Science, Engineering, and Medicine (NASEM).
In December 2019, NASEM provided a consensus report that identified the surgical procedures/medical conditions requiring research for the development of evidence-based guidelines to treat acute pain.FDA proposes to fund the development, dissemination, implementation, and evaluation of an evidence-based clinical practice guideline (CPG) for dental pain (surgical and non-surgical).
The NASEM report identified dental surgeries (e.g., third molar extraction) and dental pain as priority areas for evidence-based guideline development because of the patient populations that are affected (e.g., adolescents and young adults), the high prevalence of the procedure, and the data that documents the efficacy of nonopioid pain management strategies for this procedure.
Similarly, the most common diagnoses resulting in an opioid prescription in the emergency department were dental pain among adolescents and young adults.
The NASEM report also recommends that organizations that develop evidence-based CPGs on opioid prescribing for acute pain establish a process for disseminating, implementing, and monitoring the uptake and impacts of the CPG on opioid prescribing practices.
prescribing guidelines for indication-specific treatment of acute pain where such guidelines do not exist.
Consistent with the requirements of section 3002 of the SUPPORT Act, FDA launched an effort to develop a framework for evidence-based guidelines involving a contract with the National Academies of Science, Engineering, and Medicine (NASEM).
In December 2019, NASEM provided a consensus report that identified the surgical procedures/medical conditions requiring research for the development of evidence-based guidelines to treat acute pain.FDA proposes to fund the development, dissemination, implementation, and evaluation of an evidence-based clinical practice guideline (CPG) for dental pain (surgical and non-surgical).
The NASEM report identified dental surgeries (e.g., third molar extraction) and dental pain as priority areas for evidence-based guideline development because of the patient populations that are affected (e.g., adolescents and young adults), the high prevalence of the procedure, and the data that documents the efficacy of nonopioid pain management strategies for this procedure.
Similarly, the most common diagnoses resulting in an opioid prescription in the emergency department were dental pain among adolescents and young adults.
The NASEM report also recommends that organizations that develop evidence-based CPGs on opioid prescribing for acute pain establish a process for disseminating, implementing, and monitoring the uptake and impacts of the CPG on opioid prescribing practices.
Agency: Department of Health and Human Services
Office: Food and Drug Administration
Estimated Funding: $19,000,000
Office: Food and Drug Administration
Estimated Funding: $19,000,000
Who's Eligible
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-009.html
Additional Information of Eligibility:
Nonprofits Other Than Institutions of Higher Education· Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education) · Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education) Higher Education Institutions· Public/State Controlled Institutions of Higher Education · Private Institutions of Higher Education The following types of Higher Education Institutions are always encouraged to apply for FDA support as Public or Private Institutions of Higher Education: o Hispanic-serving Institutionso Historically Black Colleges and Universities (HBCUs)o Tribally Controlled Colleges and Universities (TCCUs) o Alaska Native and Native Hawaiian Serving Institutionso Asian American Native American Pacific Islander Serving Institutions (AANAPISIs) For-Profit Organizations· Small Businesses· For-Profit Organizations (Other than Small Businesses) Governments· State Governments · County Governments· City or Township Governments· Special District Governments· Indian/Native American Tribal Governments (Federally Recognized) · Indian/Native American Tribal Governments (Other than Federally Recognized)· U. S. Territory or Possession Other· Independent School Districts· Public Housing Authorities/Indian Housing Authorities· Native American Tribal Organizations (other than Federally recognized tribal governments)· Faith-based or Community-based Organizations· Regional Organizations
Full Opportunity Web Address:
http://grants.nih.gov/grants/guide/rfa-files/RFA-OD-20-009.html
Contact:
Agency Email Description:
Work Email
Agency Email:
Date Posted:
2021-05-25
Application Due Date:
Archive Date:
2021-05-26
Social Entrepreneurship
Spotlight
Calgary Social Enterprise Offers High-Tech Services by People with Autism
Meticulon, a project of Autism Calgary Association in partnership with the federal government and the Sinneave Family Foundation, operates as a social enterprise that renders high-tech services provided by people with autism, leveraging their natural abilities at requiring attention to detail, repetition, and sequencing.
Learn How to Identify and Avoid Grant Scams
